ERCC4 and myeloproliferative neoplasm: In our research, both homozygous and heterozygous XPF 11985A>G variant genotypes appear to be associated with a low risk of developing MPN (OR = 0.19; 95% CI = 0.11–0.33 and OR = 0.3; 95% CI = 0.21–0.43).